| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |